Skip to content

Fulgent Genetics, Inc. FLGT Non-Controlling Interests

Non-Controlling Interests at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
$300M+809%
Agilent Technologies logo
Agilent TechnologiesA

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$552.11M-7.1%
Enterprise value$536.92M+0.7%
P/S1.7×-0.3×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Fulgent Genetics, Inc.'s non-controlling interests.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fulgent Genetics, Inc.'s non-controlling interests?
Fulgent Genetics, Inc. (FLGT) reported non-controlling interests of -$5.66M in Q1 2026.
How has Fulgent Genetics, Inc.'s non-controlling interests changed year-over-year?
Fulgent Genetics, Inc.'s non-controlling interests decreased by 28.3% year-over-year, from -$4.41M to -$5.66M.
What is the long-term trend for Fulgent Genetics, Inc.'s non-controlling interests?
Over 4 years (2021 to 2025), Fulgent Genetics, Inc.'s non-controlling interests has grown at a -7.3% compound annual growth rate (CAGR), from $7.13M to -$5.27M.
What does non-controlling interests mean?
Equity attributable to minority shareholders in subsidiaries not fully owned by the parent — their proportional claim on subsidiary net assets.